- Article
Comparison of Hepatic Function and Chemotherapy-Induced Side Effects Between Pegylated Liposomal Doxorubicin (PLD), Topotecan (TOPO), and Gemcitabine in Platinum-Resistant Ovarian Cancer (PROC)
- Radu-Dumitru Dragomir,
- Marina Adriana Mercioni,
- Șerban Negru,
- Dorel Popovici,
- Sorin Săftescu,
- Andiana Roxana Blidari and
- Ioan Sas
Background/Objectives: Platinum-resistant ovarian cancer (PROC) is a major therapeutic challenge, as it responds poorly to standard platinum-based treatment, has limited treatment options, and offers a generally unfavorable prognosis. Chemotherapeuti...

